{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:04:43Z","timestamp":1790298283075,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40121-024-01035-9","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T08:02:46Z","timestamp":1725436966000},"page":"2179-2193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review"],"prefix":"10.1007","volume":"13","author":[{"given":"Chiara","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Delfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Toscanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mezzogori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bartalucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bartalucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Gambella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Raiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Morici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Daniela","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"1","key":"1035_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijmmb.2020.10.020","volume":"39","author":"J Ahmed","year":"2021","unstructured":"Ahmed J, et al. Mycoplasma hominis: an under recognized pathogen. Indian J Med Microbiol. 2021;39(1):88\u201397.","journal-title":"Indian J Med Microbiol"},{"key":"1035_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1099\/00207713-50-1-291","volume":"50 Pt 1","author":"B Pettersson","year":"2000","unstructured":"Pettersson B, et al. Updated phylogenetic description of the Mycoplasma hominis cluster (Weisburg et al. 1989) based on 16S rDNA sequences. Int J Syst Evol Microbiol. 2000;50 Pt 1:291\u2013301.","journal-title":"Int J Syst Evol Microbiol"},{"issue":"9\u201310","key":"1035_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.resmic.2017.02.009","volume":"168","author":"D Taylor-Robinson","year":"2017","unstructured":"Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res Microbiol. 2017;168(9\u201310):875\u201381.","journal-title":"Res Microbiol"},{"key":"1035_CR4","volume-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","author":"JE Bennett","year":"2019","unstructured":"Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases, vol. 2. 9th ed. Amsterdam: Elsevier; 2019.","edition":"9"},{"issue":"11","key":"1035_CR5","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jdv.15146","volume":"32","author":"P Horner","year":"2018","unstructured":"Horner P, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women?\u2014a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 2018;32(11):1845\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1035_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jmii.2017.05.004","volume":"51","author":"C Leli","year":"2018","unstructured":"Leli C, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect. 2018;51(2):220\u20135.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"1035_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/cid\/ciab061","volume":"73","author":"EL Plummer","year":"2021","unstructured":"Plummer EL, et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum associated with specific genital symptoms and clinical signs in nonpregnant women? Clin Infect Dis. 2021;73(4):659\u201368.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1035_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/clinids\/10.3.602","volume":"10","author":"S Madoff","year":"1988","unstructured":"Madoff S, Hooper DC. Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis. 1988;10(3):602\u201313.","journal-title":"Rev Infect Dis"},{"issue":"3","key":"1035_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0002-9343(90)90338-E","volume":"89","author":"DK McMahon","year":"1990","unstructured":"McMahon DK, et al. Extragenital Mycoplasma hominis infections in adults. Am J Med. 1990;89(3):275\u201381.","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"1035_CR10","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1093\/clinids\/17.Supplement_1.S243","volume":"17","author":"RD Meyer","year":"1993","unstructured":"Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis. 1993;17(Suppl 1):S243\u20139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1035_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/0002-9343(86)90812-0","volume":"80","author":"CM Roifman","year":"1986","unstructured":"Roifman CM, et al. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986;80(4):590\u20134.","journal-title":"Am J Med"},{"issue":"7","key":"1035_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242513","volume":"14","author":"P Tawfik","year":"2021","unstructured":"Tawfik P, Arndt P. Lethal hyperammonemia in a CAR-T cell recipient due to ureaplasma pneumonia: a case report of a unique severe complication. BMJ Case Rep. 2021;14(7): e242513.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"1035_CR13","first-page":"464","volume":"33","author":"P Machado","year":"2008","unstructured":"Machado P, et al. Arthritis and X-linked agammaglobulinemia. Acta Reumatol Port. 2008;33(4):464\u20137.","journal-title":"Acta Reumatol Port"},{"issue":"6591","key":"1035_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/bmj.295.6591.174","volume":"295","author":"TT Hansel","year":"1987","unstructured":"Hansel TT, Haeney MR, Thompson RA. Primary hypogammaglobulinaemia and arthritis. Br Med J (Clin Res Ed). 1987;295(6591):174\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"7","key":"1035_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.4169","volume":"1","author":"S Barmettler","year":"2018","unstructured":"Barmettler S, et al. Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia. JAMA Netw Open. 2018;1(7): e184169.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1035_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/clind\/15.3.402","volume":"15","author":"W Clough","year":"1992","unstructured":"Clough W, et al. Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus. Clin Infect Dis. 1992;15(3):402\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1035_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/ard.53.3.183","volume":"53","author":"PM Furr","year":"1994","unstructured":"Furr PM, Taylor-Robinson D, Webster AD. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann Rheum Dis. 1994;53(3):183\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1035_CR18","first-page":"383","volume":"71","author":"AD Webster","year":"1988","unstructured":"Webster AD, et al. Critical dependence on antibody for defence against mycoplasmas. Clin Exp Immunol. 1988;71(3):383\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"6 Suppl","key":"1035_CR19","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1097\/00006454-198611010-00006","volume":"5","author":"D Taylor-Robinson","year":"1986","unstructured":"Taylor-Robinson D, Furr PM, Webster AD. Ureaplasma urealyticum in the immunocompromised host. Pediatr Infect Dis. 1986;5(6 Suppl):S236\u20138.","journal-title":"Pediatr Infect Dis"},{"key":"1035_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02343-20","author":"S Stabler","year":"2021","unstructured":"Stabler S, et al. The brief case: mycoplasma hominis extragenital abscess. J Clin Microbiol. 2021. https:\/\/doi.org\/10.1128\/JCM.02343-20.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1035_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24329","volume":"36","author":"F Su","year":"2022","unstructured":"Su F, et al. Identification of sacrococcygeal and pelvic abscesses infected with invasive Mycoplasma hominis by MALDI-TOF MS. J Clin Lab Anal. 2022;36(4): e24329.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"1035_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jmoldx.2012.06.001","volume":"14","author":"KB Waites","year":"2012","unstructured":"Waites KB, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn. 2012;14(5):437\u201350.","journal-title":"J Mol Diagn"},{"issue":"7","key":"1035_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102743","volume":"9","author":"M Frolund","year":"2014","unstructured":"Frolund M, et al. Comparison between culture and a multiplex quantitative real-time polymerase chain reaction assay detecting Ureaplasma urealyticum and U. parvum. PLoS One. 2014;9(7): e102743.","journal-title":"PLoS One"},{"issue":"4","key":"1035_CR24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1128\/JCM.42.4.1528-1533.2004","volume":"42","author":"KA Stellrecht","year":"2004","unstructured":"Stellrecht KA, et al. Comparison of multiplex PCR assay with culture for detection of genital mycoplasmas. J Clin Microbiol. 2004;42(4):1528\u201333.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"1035_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jama.2022.1246","volume":"327","author":"A Hazra","year":"2022","unstructured":"Hazra A, Collison MW, Davis AM. CDC sexually transmitted infections treatment guidelines, 2021. JAMA. 2022;327(9):870\u20131.","journal-title":"JAMA"},{"issue":"4","key":"1035_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1\u2013187.","journal-title":"MMWR Recomm Rep"},{"key":"1035_CR27","volume-title":"Guidelines for the management of symptomatic sexually transmitted infections","author":"WHO","year":"2021","unstructured":"WHO. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: WHO; 2021."},{"issue":"11","key":"1035_CR28","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/j.1469-0691.2010.03155.x","volume":"16","author":"R Krausse","year":"2010","unstructured":"Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16(11):1649\u201355.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1035_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1179\/joc.2011.23.2.77","volume":"23","author":"Z Samra","year":"2011","unstructured":"Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23(2):77\u20139.","journal-title":"J Chemother"},{"issue":"Suppl 1","key":"1035_CR30","first-page":"17","volume":"18","author":"A Niccoli Asabella","year":"2015","unstructured":"Niccoli Asabella A, et al. Role of (18)F-FDG PET\/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis. Hell J Nucl Med. 2015;18(Suppl 1):17\u201322.","journal-title":"Hell J Nucl Med"},{"issue":"2","key":"1035_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/jpm11020133","volume":"11","author":"JP Pijl","year":"2021","unstructured":"Pijl JP, et al. PET\/CT imaging for personalized management of infectious diseases. J Pers Med. 2021;11(2):133.","journal-title":"J Pers Med"},{"issue":"3","key":"1035_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14058","volume":"25","author":"C Divithotewala","year":"2023","unstructured":"Divithotewala C, et al. Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: a case series and literature review. Transpl Infect Dis. 2023;25(3): e14058.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"1035_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.healun.2023.09.023","volume":"43","author":"E Farfour","year":"2024","unstructured":"Farfour E, Vasse M, Vallee A. Mollicutes-related infections in thoracic surgery including lung and heart transplantation: a systematic review. J Heart Lung Transplant. 2024;43(1):169\u201380.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"1035_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajt.2023.08.019","volume":"24","author":"PCK Tam","year":"2024","unstructured":"Tam PCK, et al. Risk factors, management, and clinical outcomes of invasive Mycoplasma and Ureaplasma infections after lung transplantation. Am J Transplant. 2024;24(4):641\u201352.","journal-title":"Am J Transplant"},{"issue":"3","key":"1035_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0163-4453(96)92441-X","volume":"33","author":"A Steuer","year":"1996","unstructured":"Steuer A, et al. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis. J Infect. 1996;33(3):235\u20137.","journal-title":"J Infect"},{"issue":"6","key":"1035_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/rheumatology\/36.6.661","volume":"36","author":"A Franz","year":"1997","unstructured":"Franz A, et al. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol. 1997;36(6):661\u20138.","journal-title":"Br J Rheumatol"},{"issue":"4","key":"1035_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/jinf.2001.0910","volume":"43","author":"C Heilmann","year":"2001","unstructured":"Heilmann C, et al. Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic. J Infect. 2001;43(4):234\u20138.","journal-title":"J Infect"},{"issue":"8","key":"1035_CR38","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1086\/424453","volume":"39","author":"P Sendi","year":"2004","unstructured":"Sendi P, Zimmerli W, Michot M. Spondylitis and arthritis due to Mycoplasma hominis: the case for awareness in undefined pleuropneumonia. Clin Infect Dis. 2004;39(8):1250\u20131.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"1035_CR39","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/j.ijid.2010.02.2253","volume":"14","author":"CR MacKenzie","year":"2010","unstructured":"MacKenzie CR, et al. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient. Int J Infect Dis. 2010;14(Suppl 3):e307\u20139.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"1035_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1053\/j.jfas.2012.10.012","volume":"52","author":"J Wynes","year":"2013","unstructured":"Wynes J, et al. Subtalar joint septic arthritis in a patient with hypogammaglobulinemia. J Foot Ankle Surg. 2013;52(2):242\u20138.","journal-title":"J Foot Ankle Surg"},{"issue":"4","key":"1035_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2169\/internalmedicine.51.6058","volume":"51","author":"H Sato","year":"2012","unstructured":"Sato H, et al. Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominis. Intern Med. 2012;51(4):425\u20139.","journal-title":"Intern Med"},{"issue":"3","key":"1035_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s15010-015-0859-6","volume":"44","author":"E Nulens","year":"2016","unstructured":"Nulens E, et al. A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity. Infection. 2016;44(3):379\u201381.","journal-title":"Infection"},{"key":"1035_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01260","volume":"26","author":"GA Ali","year":"2021","unstructured":"Ali GA, et al. An enemy in shadows-Mycoplasma hominis septic arthritis and iliopsoas abscess: case report and review of the literature. IDCases. 2021;26: e01260.","journal-title":"IDCases"},{"issue":"1","key":"1035_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-237798","volume":"14","author":"N Bozo","year":"2021","unstructured":"Bozo N, et al. Mycoplasma hominis septic arthritis in a patient with hypogammaglobinaemia and rheumatoid arthritis. BMJ Case Rep. 2021;14(1): e237798.","journal-title":"BMJ Case Rep"},{"key":"1035_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/01455613221113814","author":"B Sadhar","year":"2022","unstructured":"Sadhar B, et al. Mycoplasma hominis: a rare case of acute otitis media and facial nerve paralysis. Ear Nose Throat J. 2022. https:\/\/doi.org\/10.1177\/01455613221113814.","journal-title":"Ear Nose Throat J"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-01035-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:05:05Z","timestamp":1726931105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-01035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-01035-9","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Matteo Bassetti received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events of Angelini, Cidara, Gilead, Menarini, MSD, Pfizer, Shionogi, Multipharma. MB participated on a Data Safety Monitoring Board or Advisory Board with Angelini, Cidara, Gilead, Menarini, MSD, Pfizer, Shionogi, Multipharma. Malgorzata Mikulska is an Editorial Board member of Infectious Diseases and Therapy and\u00a0was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Chiara Russo, Emanuele Delfino, Federica Toscanini, Laura Mezzogori, Riccardo Schiavoni, Claudia Bartalucci, Emanuele Angelucci, Giulia Bartalucci, Massimilano Gambella, Anna Maria Crea, Paolo Morici, Francesca Crea, Silvia Chiola, Silvia Daniela Morbelli, and Anna Marchese have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Both patients signed an institutional consent form which includes the use of electronic medical records and the conservation of biological samples for scientific purposes. Specific consent was obtained from the surviving patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}